A randomised controlled trial (pilot study) of the use of macerated garlic in patients with cystic fibrosis who have pulmonary infection with Pseudomonas aeruginosa

Completed

• Conditions: Cystic fibrosis; Nutritional, Metabolic, Endocrine; Metabolic disorders

• Registration Number: ISRCTN21133397
• Lead Sponsor: niversity of Nottingham (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2007-03-28
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

The following patients with cystic fibrosis will be eligible:
1. Chronic pulmonary infection with P. aeruginosa
2. Can produce sputum
3. Are able to swallow the capsules
4. Over eight years
5. Are not currently suffering from an acute pulmonary exacerbation, requiring oral or intravenous antibiotics
6. Patient?s consent or parental consent with child?s assent

Exclusion Criteria

1. Prolonged clotting or platelet count below 150 x 10^9/L at baseline
2. Abnormal liver function
3. Pregnant or lactating mothers

Study & Design

• Study Type: Interventional
• Study Design: Not specified